Align Technology (ALGN) stock
NASDAQ
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 2
- Market cap
- $11.2B
- As of Nov 5, 2026
- P/E
- 22.74x
- Trailing twelve months
- P/B
- 2.59x
- Latest reported equity
- P/S
- 2.68x
- Trailing twelve months
- ROE
- 11.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $11.2B
- As of Nov 5, 2026
- P/E
- 22.74x
- Trailing twelve months
- P/B
- 2.59x
- Latest reported equity
- P/S
- 2.68x
- Trailing twelve months
- ROE
- 11.4%
- Trailing twelve months
- Dividend yield
- Not available
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
22.74x
P/B
2.59x
P/S
2.68x
Earnings and dividend metrics▾
Earnings
EPS
$7.01
Earnings per share
BPS
$61.51
Book value per share
ROE
11.4%
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $7.01 per share.
- BPS — net assets divided by the number of shares. Each share is backed by $61.51 of net assets.
- ROE — how much the company earned on shareholder equity over a year: 11.4%.
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2026 Q3)
Revenue increased 1.9% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $996M+1.9%
$978M
Jul–Sep '24
$996M
Jul–Sep '25
$1.02B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 4, 2026.
- Earnings per share increased 143.6% from the same quarter a year earlier.
- Revenue increased 1.9% from the same quarter a year earlier.
- Operating income increased 76.0% from the same quarter a year earlier.
- Net income increased 136.8% from the same quarter a year earlier.
Filed Nov 4, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KThe company said its board appointed Jennifer L. Davis as CEO-elect and a director effective October 26, 2026, and that she will serve as CEO-elect and director from November 2, 2026 and as President and CEO from December 31, 2026.Published Oct 28, 2026 · Filed Oct 28, 2026Read the summary →
- AI summary8-KThe company said total revenue for Q3 2026 was $1,014.8 million, up 1.9% year over year, and Clear Aligner revenue was $839.3 million, up 4.2%. Clear Aligner volume rose 6.6% to 690.6 thousand cases.Published Oct 28, 2026 · Filed Oct 28, 2026Read the summary →
- AI summary8-KThe company said its Board appointed Quentin Blackford, 48, as a director on August 27, 2026 and increased the size of the Board from 10 to 11 directors as a result.Published Oct 21, 2026 · Filed Aug 31, 2026Read the summary →
- The company said its board appointed Jennifer L. Davis as CEO-elect and a director effective October 26, 2026, and that she will serve as CEO-elect and director from November 2, 2026 and as President and CEO from December 31, 2026.Read the full analysis →
- The company said total revenue for Q3 2026 was $1,014.8 million, up 1.9% year over year, and Clear Aligner revenue was $839.3 million, up 4.2%. Clear Aligner volume rose 6.6% to 690.6 thousand cases.Read the full analysis →
- The company said its Board appointed Quentin Blackford, 48, as a director on August 27, 2026 and increased the size of the Board from 10 to 11 directors as a result.Read the full analysis →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Align Technology (ALGN) stock information
NASDAQ
Align Technology (ALGN) is listed on NASDAQ. Its market capitalization is about $11.2B. On trailing-twelve-month earnings the P/E ratio is 22.74, and the P/B ratio is 2.59. Return on equity is 11.4%. These figures are computed in-house from official filings and are reference information only.
Align Technology — frequently asked questions
- What is the P/E ratio of Align Technology (ALGN)?
- On a trailing-twelve-month basis, ALGN trades at a P/E ratio of 22.74. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Align Technology?
- ALGN has a market capitalization of about $11.2B. The figure moves with the share price and is refreshed each trading day.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.